Search

If you would like to learn more about our service or obtain a price quote, please fill in as much information as possible and our staff will contact you. Please note, medical emergencies cannot be addressed using this form. (* Required)

The primary goal of this study is to assess the safety and tolerability of mRNA-4359 administered alone and in combination with pembrolizumab.

Warmer months bring outdoor events, including cookouts, campfires, and fireworks displays, but they also bring the risk of burns. Robert Shesser, MD, MPH, chair and professor of the Department of Emergency Medicine at the George Washington University (GW) School of Medicine and Health Sciences,…

GW joins a nationwide network of research centers in the Northeast ALS (NEALS) Consortium who are partnering with the Sean M HEALEY & AMG Center to conduct the first ALS platform trial. The platform trial is designed in a way that allows for testing multiple drugs simultaneously while reducing…

Dr. Tamer Mansour is a pleasant and dedicated board-certified Ophthalmologist and an Assistant Clinical Professor at the George Washington University School of Medicine and Health Sciences. Following his medical school degree and ophthalmology residency at Howard University, he completed a…

This is a phase 3 open label, multi-center, randomized, active-controlled non-inferiority trial that compares the safety and effectiveness of a 6-week regimen of daily rifapentine against the current standard of 12-16 weeks of rifamycin-based treatment for latent TB infection (LTBI).

The George Washington University (GW) Medical Faculty Associates (GW MFA), is pleased to announce the appointment of Christopher T. Smedley, MPM, as the Chief Clinical Affairs and Strategy Officer. Smedley served as a consultant in this role, and officially transitioned into the position on May 1,…

Podcast Listen to Dr. Parr's podcast regarding the anesthesia and heart surgery. Press the play button below: